Detalhe da pesquisa
1.
Inequities in primary liver cancer in Europe: The state of play.
J Hepatol
; 80(4): 645-660, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237866
2.
From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy.
J Infect Dis
; 228(Suppl 3): S211-S220, 2023 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703346
3.
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.
Hepatology
; 76(1): 220-232, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919289
4.
Forecasting the long-term impact of COVID-19 on hepatitis C elimination plans in Italy: A mathematical modelling approach.
Liver Int
; 43(12): 2615-2624, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735959
5.
Securing wider EU commitment to the elimination of hepatitis C virus.
Liver Int
; 43(2): 276-291, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196744
6.
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation.
Liver Int
; 42(1): 26-37, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34582627
7.
A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions.
BMC Infect Dis
; 22(1): 58, 2022 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038987
8.
Prevalence of hepatitis C virus estimates of undiagnosed individuals in different Italian regions: a mathematical modelling approach by route of transmission and fibrosis progression with results up to January 2021.
New Microbiol
; 45(4): 249-259, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066213
9.
Impact of COVID-19 on global HCV elimination efforts.
J Hepatol
; 74(1): 31-36, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777322
10.
Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements.
Liver Int
; 41(4): 649-655, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486885
11.
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries.
Liver Int
; 41(5): 934-948, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529499
12.
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort.
BMC Infect Dis
; 21(1): 413, 2021 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33947337
13.
Hepatitis C elimination: Tailoring the approach to each country's needs and realities.
Hepatology
; 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441956
14.
Optimization of hepatitis C virus screening strategies by birth cohort in Italy.
Liver Int
; 40(7): 1545-1555, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078234
15.
Hospital HCV elimination in addition to universal precautions could reduce incidence and infection burden in Italy.
J Hepatol
; 79(5): e187-e188, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37121438
16.
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
J Hepatol
; 69(4): 896-904, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29886156
17.
Migrants and hepatitis: A tale of two worlds.
J Viral Hepat
; 30(8): 634-637, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340805
19.
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort.
Hepatology
; 66(6): 1814-1825, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28741307
20.
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
Liver Int
; 38(12): 2190-2198, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29900654